Bibliografia
Cheratite da Acanthamoeba
- Auran JD, Stan MB. Jakobiec FA – Acanthamoeba keratitis. A review of the literature. Cornea 6: 2-26; 1987
- Bagga B, Joseph J, Garg P et al. Efficacy of Topical Miltefosine in Patients with
Acanthamoeba Keratitis: A Pilot Study. Ophthalmology 126:768-770; 2019. - Dart JKG, Saw VPJ, Kilvington S – Acanthamoeba keratitis: Diagnosis and Treatment-
Update 2009. Am.J.Ophthalmol. 148: 487-499; 2009 - Dart JKG, Papa V, Rama P et al – The Orphan Drug for Acanthamoeba Keratitis (ODAK)
Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine
0.1. Ophthalmology 131: 277-287, 2024. - Elder MJ, Kilvington S, Dart JKG – A clinicopathologic study of in vitro sensitivity testing
and Acanthamoeba keratitis. Invest. Ophthalmol.Vis.Sci. 35: 1059-1064, 1994 - Elder MJ, Dart JKG – Chemotherapy for Acanthamoeba keratitis. Lancet 345: 791-792;
1995 - Hirabayashi KE, Lin CC, Ta CN. Oral miltefosine for refractory Acanthamoeba keratitis.
Am J Ophthalmol Case Rep. 19:16;2019. - Illingworth CD, Cook SD – Acanthamoeba keratitis. Surv. Ophthalmol. 42: 493-508; 1998
- Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TRG, Ficker L – Comparison of
polyhexamethylene biguanide and chlorexidine as monotherapy agents in the treatment
of Acanthamoeba keratitis. Am.J.Ophthalmol. 145: 130-135; 2008 - Narasimhan S, Madhavan HN, Lily T – Development and application of an in
vitro susceptibility test for Acanthamoeba species isolated from keratitis to
polyhexamethylene biguanide and chlorexidine. Cornea 21: 201-205; 2002 - Polat ZA, Obwaller A, Vural A, Walochnik J. Efficacy of miltefosine for topical treatment of
Acanthamoeba keratitis in Syrian hamsters. Parasitol Res 110:515-20; 2012. - Raghavan A, Nair AV, Kavitha N et al. Voriconazole in the successful management of a
case of Acanthamoeba-Cladosporium keratitis. Am J Ophthalmol 16:22:101-107; 2021. - Seal DV, Hay J, Kirkness CM – Chlorexidine or polyhexamethylene biguanide for
Acanthamoeba keratitis. Lancet 345: 136; 1995 - Schuster FL, Guglielmo BJ, Visvesvara GS – In vitro activity of miltefosine and
voriconazole on clinical isolates of free-living amoebas: Balamuthia mandrillaris,
Acanthamoeba spp., and Naegleria fowleri. J.Eukaryot.Microbiol. 53: 1212-126; 2006 - Tirado-Angel J, Gabriel MM, Wilson LA, Ahearn DG – Effects of polyhexamethylene
biguanide and chlorexidine on four species of Acanthamoeba in vitro. Curr. Eye Res. 15:
225-228; 1996 - Tu EY, Joslin CE, Shoff ME. Successful treatment of chronic stromal acanthamoeba
keratitis with oral voriconazole monotherapy. Cornea 29: 1066-8; 2010. - Vemulakonda GA, Hariprasad SM, Mieler WF et al. Aqueous and vitreous concentrations
following topical administration of 1% voriconazole in humans. Arch Ophthalmol. 126: 18-
22; 2008. - Walochnik J, Duchêne M, Seifert K et al. Cytotoxic activities of alkylphosphocholines
against clinical isolates of Acanthamoeba spp. Antimicrob Agents Chemother 46:695-
701; 2002. - Wysenbeek YS, Blank-Porat D, Harizman N, Wygnanski-Jaffe T, Keller N, Avni I – The
reculture technique: individualizing the treatment of Acanthamoeba keratitis. Cornea 19:
464-467; 2000
